Feasibility of a Trial Evaluating the Effectiveness of Occupational Therapy in Parkinson's Disease
NCT ID: NCT01010529
Last Updated: 2011-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2009-10-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness Study of Occupational Therapy in Parkinson's Disease
NCT01336127
Rehabilitation of Postural Abnormalities in Parkinson's Disease
NCT03741959
Cost-effectiveness of Nursing Interventions for Patients With PD
NCT03830190
Efficiency of Physiotherapeutic Care in Parkinson's Disease
NCT00330694
The Effectiveness of Motor-motor and Motor-cognitive Dual-task Training Interventions on Balance in People With Parkinson's Disease: a Feasibility Study
NCT05710588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
occupational therapy
occupational therapy
Patients in the experimental group will receive 10 weeks (maximum 16 hours) occupational therapy according to a treatment protocol, which is based on the Dutch evidence based guideline for occupational therapy in Parkinson's Disease and refined for this study.
No occupational therapy
Patients and their caregivers in the control group will have no occupational therapy intervention until their last measurement has taken place (3 months).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
occupational therapy
Patients in the experimental group will receive 10 weeks (maximum 16 hours) occupational therapy according to a treatment protocol, which is based on the Dutch evidence based guideline for occupational therapy in Parkinson's Disease and refined for this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* home dwelling
* indication for occupational therapy (according to criteria in the evidence based guideline)
* available to provide informal support minimal two times a week to a patient who participates in the study.
Exclusion Criteria
* comorbidity with symptoms that interfere with actively taking part in the intervention (e.g psychosis, severe heart condition). Or limitations in activities are dominated by the co morbid condition rather than by Parkinson's Disease.
* current participation in other allied health research (IMPACT, PARKFIT, ERGODIM)
* having received occupational therapy intervention in the last 12 months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stichting Nuts Ohra
OTHER
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Radboud University Nijmegen Medical Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marten Munneke, Phd
Role: PRINCIPAL_INVESTIGATOR
UMC St Radboud
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meander Medisch Centrum, locatie Elisabeth
Amersfoort, , Netherlands
Gelre Ziekenhuizen, locatie Lukas
Apeldoorn, , Netherlands
Alysis Zorggroep, Ziekenhuis Rijnstate
Arnhem, , Netherlands
Ziekenhuis Rivierenland Tiel
Tiel, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FNO-0804-66
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.